Leerink Partners Remains Sidelined on Medivation (MDVN) Following an EPS Beat
Leerink Partners maintained a Market Perform rating on Medivation (NASDAQ: MDVN), and cut the price target to $39.00 (from $41.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
